Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.980
-0.010 (-0.50%)
At close: Oct 31, 2025, 4:00 PM EDT
1.950
-0.030 (-1.52%)
After-hours: Oct 31, 2025, 4:00 PM EDT
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $177.74 million as of October 31, 2025. Its market cap has increased by 19.51% in one year.
Market Cap
177.74M
Enterprise Value
139.68M
1-Year Change
19.51%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $177.74M, an increase of 41.95%. That is a compound annual growth rate of 2.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 177.74M | 7.34% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | 334.40M | -36.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |